WebPharmaceutics is a peer-reviewed, open access journal on the science and technology of pharmaceutics and biopharmaceutics, and is published monthly online by MDPI. The Spanish Society of Pharmaceutics and … WebBrYet is a privately-owned biotech company focused on the discovery and development of novel physics-based, first-in-class therapies for metastatic liver and lung cancers. … BrYet has identified a lead product from these platforms: ML-016 (iNPG-pDox), a …
Fusion Antibodies names Dr Richard Jones as its new …
WebA dynamic, results-orientated and highly skilled senior executive with a sustained record of achievement in science, business, corporate development and commercialization in the … WebAn active scientist-entrepreneur, he served in the past as tenured professor in engineering and/or medicine, at University of Texas institutions, at the University of California … blu ink real estate bellingham
European Researchers
WebAs CEO of BrYet Europe, global technology entrepreneur Lorenzo Pradella oversees BrYet’s European operations and partnerships. With a longstanding history of bringing innovative products to market approval in the healthcare ecosystem, Pradella brings more than 30 years of experience in R&D, business development, and venture capital. Prior to ... WebNanoInnovation 2024, Rome September, 20-23, Conference & Exhibition WebJan 17, 2024 · BrYet Pharma is developing drugs for the prevention, treatment, and cure of metastatic cancers using nanoporous silicon microparticles. Whether it is creating … clerk of courts lehigh